Free Trial

Virtu Financial LLC Buys Shares of 13,486 Rentokil Initial PLC (NYSE:RTO)

Rentokil Initial logo with Business Services background

Key Points

  • Virtu Financial LLC has acquired a new stake of 13,486 shares in Rentokil Initial PLC, valued at approximately $309,000, as revealed in their 13F filing with the SEC.
  • Rentokil Initial recently had mixed analyst ratings, with Sanford C. Bernstein downgrading it from "market perform" to "underperform" while Deutsche Bank maintained a "buy" rating.
  • The company has announced a semi-annual dividend of $0.2738 to be paid on September 23rd, with an ex-dividend date of August 15th, representing a yield of 240.0%.
  • Looking to export and analyze Rentokil Initial data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Virtu Financial LLC bought a new stake in Rentokil Initial PLC (NYSE:RTO - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,486 shares of the company's stock, valued at approximately $309,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of RTO. Wealthquest Corp acquired a new position in Rentokil Initial in the first quarter valued at approximately $66,000. Russell Investments Group Ltd. boosted its position in shares of Rentokil Initial by 63.9% during the fourth quarter. Russell Investments Group Ltd. now owns 3,287 shares of the company's stock worth $83,000 after buying an additional 1,281 shares during the period. Versant Capital Management Inc acquired a new position in shares of Rentokil Initial during the first quarter worth approximately $143,000. GAMMA Investing LLC boosted its position in shares of Rentokil Initial by 996.0% during the first quarter. GAMMA Investing LLC now owns 9,206 shares of the company's stock worth $211,000 after buying an additional 8,366 shares during the period. Finally, Laird Norton Wetherby Wealth Management LLC acquired a new position in shares of Rentokil Initial during the fourth quarter worth approximately $246,000. 9.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Sanford C. Bernstein downgraded Rentokil Initial from a "market perform" rating to an "underperform" rating in a research report on Thursday, May 15th. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Rentokil Initial in a research report on Monday, July 21st.

Check Out Our Latest Report on RTO

Rentokil Initial Trading Down 2.5%

Rentokil Initial stock opened at $24.51 on Friday. The company's fifty day simple moving average is $23.96 and its 200-day simple moving average is $23.67. The company has a quick ratio of 0.72, a current ratio of 0.81 and a debt-to-equity ratio of 0.59. Rentokil Initial PLC has a 12 month low of $19.60 and a 12 month high of $34.07. The stock has a market cap of $12.38 billion, a P/E ratio of 16.23, a P/E/G ratio of 4.37 and a beta of 0.92.

Rentokil Initial Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Tuesday, September 23rd. Investors of record on Friday, August 15th will be issued a $0.2738 dividend. The ex-dividend date is Friday, August 15th. This represents a yield of 240.0%. Rentokil Initial's dividend payout ratio is currently 45.70%.

Rentokil Initial Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Articles

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines